1. Home
  2. Search

Search

Search results

173 results found

Talia Zenlea, M.D.

Person: Gastroenterologist, Women's College Hospital, Founder, BellyBlog.ca
Dr. Zenlea received her medical degree from the University of Vermont. She completed her residency in internal Medicine at Yale University/Yale-New Haven Hospital, where she served as Chief Resident, followed by 3 years of subspecialty training in gastroenterology at Harvard University/Beth Israel...

Joseph Frasca, M.D.

Person: Gastroenterologist, Rush University Medical Center, Assistant Professor, Department of Internal Medicine
Dr. Frasca’s academic interests are focused on several areas in inflammatory bowel disease (IBD), including the role of diet and obesity, geographic determinants of outcomes, quality improvement, pharmacokinetics of current IBD medications, and clinical trials for new IBD therapies.

Fellowship and Education

Page
IBD Fellowship The treatment of Inflammatory Bowel Disease (Crohn's disease and Ulcerative Colitis) has changed significantly in the last 10 years. Advances in pharmacologic therapies, imaging modalities and molecular markers have revolutionized management of patients with these conditions. This has...

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.

Publication: Journal Article
Wang, Pengyun, Muhammed Yuksel, Stella Gabeta, Jonathon Graham, Munther Hussain, Laura Jayne Blackmore, Xiaohong Huang, et al. 2025. “HLA Alleles Predisposing to Autoimmunity Are Linked to Impaired Immunoregulation in Patients With Juvenile Autoimmune Liver Disease and in Their First-Degree Relatives.”. Journal of Autoimmunity 154: 103436.

Anti-tumor Necrosis Factor Drug Concentration Is Not Associated with Disease Outcomes in Pouchitis: A Retrospective, International Study.

Publication: Journal Article
Honap, Sailish, Bénédicte Caron, Jacob E Ollech, Maya Fischman, Konstantinos Papamichael, Djuna De Jong, Krisztina B Gecse, et al. 2025. “Anti-Tumor Necrosis Factor Drug Concentration Is Not Associated With Disease Outcomes in Pouchitis: A Retrospective, International Study.”. Digestive Diseases and Sciences 70 (4): 1320-27.